Simpler Grants.gov #PAR-25-324

NCI MERIT (R37) Award Extension for Early Stage Cancer Researchers

This opportunity from the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), seeks to extend research funding for Early Stage Investigators (ESIs) in cancer research through the MERIT (R37) Award Extension Request. - Government Buyer: - National Institutes of Health (NIH) - National Cancer Institute (NCI) - Products/Services Requested: - Extended grant support for cancer research projects - Research areas include cancer cause, prevention, treatment, detection, diagnosis, control, biology, and cancer centers - Up to 7 years of support, provided in two segments - OEMs and Vendors: - No specific OEMs or vendors are mentioned, as this is a research grant opportunity - Unique or Notable Requirements: - Applicants must be Early Stage Investigators (ESIs) - Open to a wide range of organizations, including educational institutions, government entities, nonprofits, businesses, and minority-serving institutions - No cost sharing or matching required - Focused on supporting ESIs in establishing their research careers in cancer research

Description

The National Cancer Institute (NCI) Method to Extend Research in Time (MERIT) (R37) Award provides extended grant support to Early Stage Investigators (ESIs). This award offers flexibility, opportunity for creativity and innovation, and additional time to successfully launch careers before submitting renewal applications. Eligible investigators can obtain up to 7 years of support in two segments. The award supports research in cancer cause and prevention, treatment, detection, diagnosis, control, biology, and cancer centers support grants.

View original listing